Lantheus Holdings (LNTH) Non-Current Deferred Tax Liability (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly Non-Current Deferred Tax Liability came in at $54.1 million in Q2 2026, up 1.03% quarter-over-quarter from $53.5 million in Q1 2026.
Powered by 
Analysis
Lantheus Holdings (LNTH) Non-Current Deferred Tax Liability (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Non-Current Deferred Tax Liability for 5 consecutive years, with $54.1 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non-Current Deferred Tax Liability changed N/A year-over-year to $54.1 million in Q2 2026; TTM through Jun 2026 was $54.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $54.2 million, changed N/A from the prior year.
- Non-Current Deferred Tax Liability was $54.1 million for Q2 2026 at Lantheus Holdings, up from $53.5 million in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $55.1 million in Q3 2025 and troughed at $53.5 million in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn |
| 10 | Prenetics Global | 357.49 Mn | 298.35 Mn | 30.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 54.06 Mn |
| Mar 31, 2026 | 53.51 Mn |
| Dec 31, 2025 | 54.25 Mn |
| Sep 30, 2025 | 55.08 Mn |
| Dec 31, 2016 | 33.20 Mn |
| Mar 31, 2016 | 200,000.00 |
| Dec 31, 2015 | 32.90 Mn |
| Dec 31, 2014 | 247,000.00 |